Cite

HARVARD Citation

    Cingolani, L. et al. (n.d.). P542 Short term efficacy, safety and thromboembolic risk of tofacitinib in moderate to severe Ulcerative Colitis. Journal of Crohn's and colitis. pp. i668-i669. [Online]. 
  
Back to record